Key Points
-
The control of the cell cycle is vital in determining the size of an organism and the size and cellular makeup of its individual organs. The vertebrate retina is a valuable model for studying cell-cycle regulation, because retinal progenitor cells generate a variety of cell types in a highly stereotypical manner, requiring precise coordination of cell proliferation and cell-cycle exit.
-
Cell proliferation during development of the central nervous system (CNS) is regulated by a combination of intrinsic and extrinsic factors. Early during development, extrinsic factors signal progenitor cells to upregulate genes that drive cell cycle progression, or to downregulate genes that encourage cell-cycle exit. Later, the emphasis is shifted towards promoting cell-cycle exit or decreasing the production of mitosis-promoting factors.
-
After M phase, progenitor cells decide either to undergo a further round of proliferation or to terminally differentiate. In cells that continue to proliferate, the retinoblastoma (Rb) protein or a related family member becomes phosphorylated by a cyclin–cyclin-dependent kinase complex. This phosphorylation step is blocked if the cell decides to exit the cell cycle.
-
Cyclin-kinase inhibitors (CKIs) have diverse roles in the CNS. p27Xic1, a Xenopus protein that belongs to the Cip/Kip family, regulates proliferation, Müller glia cell-fate specification and possibly bipolar fate specification, whereas the rodent equivalent p27Kip1 primarily regulates cell-cycle exit. Like p27Xic1, the rodent p57Kip2 has a dual role, regulating both cell-cycle exit and specification of amacrine cells in the postnatal retina.
-
Retinal progenitor cells are heterogeneous in their expression of components of the cell-cycle machinery (for example, p27Kip1 versus p57Kip2, or cyclin D1 versus cyclin D3). This could reflect intrinsic differences between progenitor cells, or extracellular cues might instruct them to exit the cell cycle at different times.
-
In the rodent retina, cell-cycle exit is a two-step process: cyclin D1 is downregulated, then one of the CKIs is upregulated. Cyclin D1 knockout mice show reduced retinal progenitor cell proliferation, whereas p27Kip1- or p57Kip2-deficient mice show extra cell division in the retina. In mice deficient for both cyclin D1 and p27Kip1, the retina develops normally.
-
Progenitor cells possess mechanisms to compensate for perturbations in the cell-cycle machinery; for example, the effects of the cyclin D1 knockout are partially counteracted by the upregulation of cyclin D3. By contrast, there is no known mechanism to compensate for mutations in Rb.
-
Apoptosis can also compensate for the deregulation of proliferation; for example, in CKI knockout mice, increased apoptosis is seen in the inner neuroblastic layer of the retina.
-
During stress or injury, glial cells in the adult CNS can be induced to divide. After retinal injury, p27Kip1 is downregulated and Müller glia re-enter the cell cycle. To prevent uncontrolled proliferation, they downregulate cyclin D3 and upregulate glial fibrillary acidic protein. In p27Kip1-deficient mice, Müller glia initiate reactive gliosis during the final stages of retinal development, leading to retinal dysplasia. Knocking out p27Kip1 produces the same changes in protein levels as injury, indicating that p27Kip1 downregulation is critical to regulate Müller cell proliferation.
Abstract
Recent studies have shown that components of the cell-cycle machinery can have diverse and unexpected roles in the retina. Cyclin-kinase inhibitors, for example, have been implicated as regulators of cell-fate decisions during histogenesis and reactive gliosis in the adult tissue after injury. Also, various mechanisms have been identified that can compensate for extra rounds of cell division when the normal timing of the cell-cycle exit is perturbed. Surprisingly, distinct components of the cell-cycle machinery seem to be used during different stages of development, and different organisms might rely on distinct pathways. Such detailed studies on the regulation of proliferation in complex multicellular tissues during development have not only advanced our knowledge of the ways in which proliferation is controlled, but might also help us to understand the degenerative disorders that are associated with gliosis and some types of tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Masui, Y. & Markert, C. L. Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J. Exp. Zool. 177, 129–145 ( 1971).
Smith, L. D. & Ecker, R. E. The interaction of steroids with Rana pipiens oocytes in the induction of maturation. Dev. Biol. 25, 232–247 ( 1971).
Lohka, M. J., Hayes, M. K. & Maller, J. L. Purification of maturation-promoting factor, an intracellular regulator of early mitotic events. Proc. Natl Acad. Sci. USA 85, 3009–3013 (1988).
Lee, M. G. & Nurse, P. Cell cycle genes of the fission yeast . Sci. Prog. 71, 1–14 (1987).
Dunphy, W. G., Brizuela, L., Beach, D. & Newport, J. The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis . Cell 54, 423–431 (1988).
Hunt, T. Maturation promoting factor, cyclin and the control of M-phase. Curr. Opin. Cell Biol. 1, 268–274 ( 1989).
Meijer, L. & Guerrier, P. Maturation and fertilization in starfish oocytes. Int. Rev. Cytol. 86, 129 –196 (1984).
Lee, M. G. & Nurse, P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 327, 31–35 ( 1987).Highlights one of the most compelling examples of the evolutionarily conserved action of a cell-cycle protein.
Tannoch, V. J., Hinds, P. W. & Tsai, L. H. Cell cycle control. Adv. Exp. Med. Biol. 465, 127–140 ( 2000).
Gitig, D. M. & Koff, A. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Methods Mol. Biol. 142, 109–123 ( 2000).
Zhu, L. & Skoultchi, A. I. Coordinating cell proliferation and differentiation. Curr Opin Genet Dev 11, 91–97 (2001).
Livesey, F. J. & Cepko, C. L. Vertebrate neural cell fate determination: lessons from the retina. Nature Rev. Neurosci. 2, 109–118 ( 2001).
Cepko, C. L., Golden, J. A., Szele, F. G. & Lin, J. in Molecular and Cellular Approaches to Neural Development (eds Cowan, W. M., Zipursky, S. L. & Jessell, T. M.) (Oxford Univ. Press, New York, 1997).
Finlay, B. L. & Darlington, R. B. Linked regularities in the development and evolution of mammalian brains. Science 268, 1578–1584 (1995). Data on the size of brain components and the order of neurogenesis was compiled from over 130 species to generate a nonlinear function that can be used to predict the outcome of changes in the rate or duration of neurogenesis on brain structure.
Reichenbach, A. et al. The Müller (glial) cell in normal and diseased retina: a case for single-cell electrophysiology. Ophthalmic. Res. 29, 326–340 (1997).
Ide, C. F. et al. Cellular and molecular correlates to plasticity during recovery from injury in the developing mammalian brain. Prog. Brain Res. 108, 365–377 ( 1996).
Ridet, J. L., Malhotra, S. K., Privat, A. & Gage, F. H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20, 570–577 (1997); erratum 21, 80 (1998). PubMed
Sahel, J. A., Albert, D. M. & Lessell, S. Proliferation of retinal glia and excitatory amino acids . Ophtalmologie 4, 13–16 (1990).
Bringmann, A. et al. Role of glial K(+) channels in ontogeny and gliosis: a hypothesis based upon studies on Müller cells. Glia 29, 35–44 (2000).
Dyer, M. A. & Cepko, C. L. Control of Müller glial cell proliferation and activation following retinal injury. Nature Neurosci. 3, 873–880 ( 2000).p27Kip1 was found to be a key regulator of Müller glial-cell proliferation during reactive gliosis.
Prados, M. D. & Levin, V. Biology and treatment of malignant glioma. Semin. Oncol. 27, 1– 10 (2000).
Humphrey, M. F., Constable, I. J., Chu, Y. & Wiffen, S. A quantitative study of the lateral spread of Müller cell responses to retinal lesions in the rabbit. J. Comp. Neurol. 334 , 545–558 (1993).
Ohnuma, S., Philpott, A., Wang, K., Holt, C. E. & Harris, W. A. p27Xic1, a Cdk inhibitor, promotes the determination of glial cells in Xenopus retina. Cell 99, 499–510 ( 1999).The first example of a role for a vertebrate cyclin-kinase inhibitor in cell-fate specification.
Levine, E. M., Close, J., Fero, M., Ostrovsky, A. & Reh, T. A. p27Kip1 regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 219, 299–314 (2000).
Dyer, M. A. & Cepko, C. L. p57Kip2 regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 127, 3593– 3605 (2000).
Dyer, M. A. & Cepko, C. L. The p57Kip2 cyclin kinase inhibitor is expressed by a restricted set of amacrine cells in the rodent retina. J. Comp. Neurol. 429, 601 –614 (2001).
Dyer, M. A. & Cepko, C. L. p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations . J. Neurosci. (in the press).The first evidence that retinal progenitor cells might use different mechanisms to exit the cell cycle during development.
Kroll, K. L., Salic, A. N., Evans, L. M. & Kirschner, M. W. Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation. Development 125, 3247–3258 (1998).
Artavanis-Tsakonas, S., Rand, M. D. & Lake, R. J. Notch signaling: cell fate control and signal integration in development. Science 284, 770– 776 (1999).
Baker, N. E. Notch signaling in the nervous system. Pieces still missing from the puzzle . Bioessays 22, 264–273 (2000).
Dubois-Dalcq, M. & Murray, K. Why are growth factors important in oligodendrocyte physiology? Pathol. Biol. (Paris) 48, 80–86 ( 2000).
Wechsler-Reya, R. J. & Scott, M. P. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22, 103–114 ( 1999).
Ahlgren, S. C. & Bronner-Fraser, M. Inhibition of sonic hedgehog signaling in vivo results in craniofacial neural crest cell death. Curr. Biol. 9, 1304– 1314 (1999).
Jensen, A. M. & Wallace, V. A. Expression of Sonic hedgehog and its putative role as a precursor cell mitogen in the developing mouse retina. Development 124, 363– 371 (1997).
Lu, N. & DiCicco-Bloom, E. Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc. Natl Acad. Sci. USA 94, 3357 –3362 (1997).
Dicicco-Bloom, E., Lu, N., Pintar, J. E. & Zhang, J. The PACAP ligand/receptor system regulates cerebral cortical neurogenesis. Ann. NY Acad. Sci. 865, 274–289 ( 1998).
Lindholm, D., Skoglosa, Y. & Takei, N. Developmental regulation of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor 1 in rat brain: function of PACAP as a neurotrophic factor. Ann. NY Acad. Sci. 865, 189–196 (1998).
Mehler, M. F. & Gokhan, S. Postnatal cerebral cortical multipotent progenitors: regulatory mechanisms and potential role in the development of novel neural regenerative strategies. Brain Pathol. 9, 515–526 (1999).
Dreyfus, H. et al. Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents. Ann. NY Acad. Sci. 845, 240–252 (1998).
Dominguez, M., Wasserman, J. D. & Freeman, M. Multiple functions of the EGF receptor in Drosophila eye development. Curr. Biol. 8, 1039 –1048 (1998).
Ilia, M. & Jeffery, G. Retinal cell addition and rod production depend on early stages of ocular melanin synthesis. J. Comp. Neurol. 420, 437–444 ( 2000).
Jeffery, G. The retinal pigment epithelium as a developmental regulator of the neural retina. Eye 12, 499–503 (1998).
Mehler, M. F., Mabie, P. C., Zhu, G., Gokhan, S. & Kessler, J. A. Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev. Neurosci. 22, 74– 85 (2000).
Helm, G. A., Alden, T. D., Sheehan, J. P. & Kallmes, D. Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review. Neurosurgery 46, 1213–1222 (2000).
Harland, R. Neural induction. Curr. Opin. Genet. Dev. 10, 357–362 (2000).
Ebendal, T., Bengtsson, H. & Soderstrom, S. Bone morphogenetic proteins and their receptors: potential functions in the brain. J. Neurosci. Res. 51, 139–146 (1998).
Patapoutian, A. & Reichardt, L. F. Roles of Wnt proteins in neural development and maintenance. Curr. Opin. Neurobiol. 10, 392–399 ( 2000).
Smalley, M. J. & Dale, T. C. Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev. 18, 215–230 (1999).
Anlar, B., Sullivan, K. A. & Feldman, E. L. Insulin-like growth factor-I and central nervous system development. Horm. Metab. Res. 31, 120–125 (1999).
Lillien, L. & Cepko, C. Control of proliferation in the retina: temporal changes in responsiveness to FGF and TGF alpha. Development 115, 253–266 ( 1992).
Rowe, J. M. & Liesveld, J. L. Hematopoietic growth factors and acute leukemia. Cancer Treat. Res. 99, 195–226 (1999).
Crawford, J., Foote, M. & Morstyn, G. Hematopoietic growth factors in cancer chemotherapy . Cancer Chemother. Biol. Response Modif. 18, 250–267 (1999).
Marsh, J. C. Results of immunosuppression in aplastic anaemia. Acta Haematol. 103, 26–32 ( 2000).
Bass, J., Oldham, J., Sharma, M. & Kambadur, R. Growth factors controlling muscle development. Domest. Anim. Endocrinol. 17, 191–197 (1999).
Gomer, R. H. & Ammann, R. R. A cell-cycle phase-associated cell-type choice mechanism monitors the cell cycle rather than using an independent timer. Dev. Biol. 174, 82– 91 (1996).One of the best-characterized examples of the cell-cycle phase-dependent response to developmental cues.
McConnell, S. K. & Kaznowski, C. E. Cell cycle dependence of laminar determination in developing neocortex. Science 254, 282–285 ( 1991).A series of transplantation experiments are described in the developing neocortex that demonstrate a correlation between cell-cycle phase and the ability to respond to developmental cues.
Belliveau, M. J. & Cepko, C. L. Extrinsic and intrinsic factors control the genesis of amacrine and cone cells in the rat retina. Development 126, 555– 566 (1999).Shows that the competence of retinal progenitor cells to respond to the extrinsic cues that regulate amacrine-cell fate specification might be cell-cycle-phase restricted.
Sherr, C. J. Cancer cell cycles. Science 274, 1672– 1677 (1996).
Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995).
Morgan, D. O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261– 291 (1997).
Vidal, A. & Koff, A. Cell-cycle inhibitors: three families united by a common cause. Gene 247, 1– 15 (2000).
Durand, B. & Raff, M. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22, 64–71 (2000).
Durand, B., Gao, F. B. & Raff, M. Accumulation of the cyclin-dependent kinase inhibitor p27Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16, 306–317 ( 1997).
Young, R. W. Cell differentiation in the retina of the mouse. Anat Rec, 212, 199–205 (1985).
Sicinski, P. et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621– 630 (1995).
Ma, C., Papermaster, D. & Cepko, C. L. A unique pattern of photoreceptor degeneration in cyclin D1 mutant mice. Proc. Natl Acad. Sci. USA 95 , 9938–9943 (1998).
Geng, Y. et al. Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc. Natl Acad. Sci. USA 98, 194–199 (2001).
Fero, M. L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice . Cell 85, 733–744 (1996).
Zhang, P. et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151–158 ( 1997).Several developmental defects observed in the p57-deficient mice could not be explained as the result of proliferation defects. This led to the proposal that cyclin-kinase inhibitors might be directly involved in cell-fate specification and/or differentiation.
Tong, W. & Pollard, J. W. Genetic evidence for the interactions of cyclin D1 and p27Kip1 in mice. Mol. Cell Biol. 21, 1319–1328 ( 2001).
O'Connor, L., Huang, D. C., O'Reilly, L. A. & Strasser, A. Apoptosis and cell division. Curr. Opin. Cell Biol. 12, 257–263 (2000).
Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).
Lee, E. Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288– 294 (1992).References 72 and 73 describe the phenotype of Rb-deficient mice and serve as one of the most dramatic examples of species-specific use of cell-cycle components. Human Rb+/− retinae develop retinoblastoma, whereas mouse Rb+/− retinae do not.
Maandag, E. C. et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13, 4260–4268 (1994).
DiCiommo, D., Gallie, B. L. & Bremner, R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin. Cancer Biol. 10, 255–269 (2000).
Robanus-Maandag, E. et al. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev. 12, 1599– 1609 (1998).
Dowling, J. E. The Retina — An Approachable Part of the Brain (Harvard Univ. Press, Cambridge, Massachusetts, 1987).
Masland, R. H. The functional architecture of the retina. Sci. Am. 255, 102–111 (1986).
Jeon, C. J., Strettoi, E. & Masland, R. H. The major cell populations of the mouse retina. J. Neurosci. 18, 8936–8946 (1998).
Nork, T. M., Ghobrial, M. W., Peyman, G. A. & Tso, M. O. Massive retinal gliosis. A reactive proliferation of Müller cells. Arch. Ophthalmol. 104, 1383–1389 (1986).
Norton, W. T., Aquino, D. A., Hozumi, I., Chiu, F. C. & Brosnan, C. F. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17, 877 –885 (1992).
Alexander, F. Neuroblastoma. Urol. Clin. North Am. 27, 383–392 (2000).
Weiss, W. A. Genetics of brain tumors. Curr. Opin. Pediatr. 12, 543–548 (2000).
DeAngelis, L. M. Brain tumors. N. Engl. J. Med. 344, 114– 123 (2001).
Acknowledgements
We would like to thank Margaret H. Baron for continued support, Brenda L. Gallie and Rod Bremner for sharing pre-publication results, and Seo-Hee Cho for critical reading of the manuscript. Research support was from the National Eye Institute. A grant from the NRSA grant and the Charles H. Revson fellowship for biomedical research supported M.A.D.
Author information
Authors and Affiliations
Glossary
- DYSPLASIA
-
Premalignant change characterized by alteration in size, shape and organization of the cellular elements of a tissue.
- MÜLLER GLIA
-
The main glial cell type present in the retina.
- BROMODEOXYURIDINE
-
Thymidine analogue that incorporates into the DNA of dividing cells.
- RETROVIRUS
-
Virus composed of single-stranded RNA enclosed by a protein capsid and surrounded by a lipid envelope.
- CALBINDIN
-
Calcium-binding protein that might function as a calcium buffer.
Rights and permissions
About this article
Cite this article
Dyer, M., Cepko, C. Regulating proliferation during retinal development. Nat Rev Neurosci 2, 333–342 (2001). https://doi.org/10.1038/35072555
Issue Date:
DOI: https://doi.org/10.1038/35072555
This article is cited by
-
Construction and characterization of EGFP reporter plasmid harboring putative human RAX promoter for in vitro monitoring of retinal progenitor cells identity
BMC Molecular and Cell Biology (2021)
-
Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System
Molecular Neurobiology (2020)
-
A hidden footprint: embryological origins of age related macular degeneration
Eye (2019)
-
Small Molecule GSK-J1 Affects Differentiation of Specific Neuronal Subtypes in Developing Rat Retina
Molecular Neurobiology (2019)
-
Nucleosomes positioning around transcriptional start site of tumor suppressor (Rbl2/p130) gene in breast cancer
Molecular Biology Reports (2018)